StocksTelegraph
S&P 500—NASDAQ—DOW—RUSSELL—
NASDAQ · BIAF·Healthcare

bioAffinity Technologies, Inc. Stock Analysis & AI Score

bioAffinity Technologies, Inc. (BIAF) has an ST Score of 43.3 (C), driven by its Valuation (B+) and held back by its Profitability (F). Analysts rate it Hold.

Market Closed
$7.83
Prev Close
—
Market Cap
—
Day Range
—
52W Range
—
P/E
—
EPS (TTM)
—
Volume
—
Avg —
Beta
—
43
ST Score
43.3/100C

Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.

As of
AI Daily Briefing
Analysis by AI
Price History
—
Technical Indicators
FMP
Earnings Surprises
Analyst Forecast
Revenue Mix

Company Information

Employees—
CEO—
SectorHealthcare
IndustryMedical - Diagnostics & Research
IPO Date—
Website—
Country—
ExchangeNASDAQ

SEC Filings

Annual Report (10-K)

Filing DateAcceptedLink
Loading…

Quarterly Report (10-Q)

Filing DateAcceptedLink
Loading…
Analyst Price Target
ESG Score
Latest News

ST Score

BIAF
43.3out of 100
Grade C

bioAffinity Technologies, Inc. (BIAF) has an ST Score of 43.3 (C), driven by its Valuation (B+) and held back by its Profitability (F). Analysts rate it Hold.

Strongest
ValuationB+
Weakest
ProfitabilityF
All factor grades
  • ValuationB+
  • GrowthB
  • Financial StrengthC+
  • MomentumC
  • ProfitabilityF
  • Piotroski3/9
Score methodology
Press Releases

Contact

BIAF stock: frequently asked questions

What is BIAF's ST Score?

bioAffinity Technologies, Inc. (BIAF) has an ST Score of 43.3 (C), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Is BIAF a buy, hold, or sell?

Analysts rate BIAF a Hold. Our ST Score grades it C (43.3/100). The ST Score is a data-driven signal, not a recommendation.

What are BIAF's factor grades?

Valuation B+, Profitability F, Financial Strength C+, Momentum C, Growth B.

What is BIAF's valuation grade?

bioAffinity Technologies, Inc. (BIAF) earns a valuation grade of B+, measured against Medical - Diagnostics & Research peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

What is BIAF's growth grade?

bioAffinity Technologies, Inc. (BIAF) earns a growth grade of B, measured against Medical - Diagnostics & Research peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

What is BIAF's profitability grade?

bioAffinity Technologies, Inc. (BIAF) earns a profitability grade of F, measured against Medical - Diagnostics & Research peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

What is BIAF's financial strength grade?

bioAffinity Technologies, Inc. (BIAF) earns a financial strength grade of C+, measured against Medical - Diagnostics & Research peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

What is BIAF's Piotroski score?

bioAffinity Technologies, Inc. (BIAF) has a Piotroski F-Score of 3 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.